Q1 2023 Holdings
Filed 2023-05-15 | 34 holdings | $132.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $37.0M | 2,305,558 | 27.9% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $33.0M | 3,000,000 | 24.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $27.5M | 3,400,000 | 20.7% |
| Annexon Inc(ANNX) | COM | 03589W102 | $18.8M | 4,886,616 | 14.2% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $8.3M | 2,485,638 | 6.3% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $5.2M | 1,642,210 | 3.9% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $2.3M | 1,937,207 | 1.8% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $110.1K | 8,300,000 | 0.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $93.3K | 3,577,267 | 0.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $79.3K | 3,081,307 | 0.1% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $42.2K | 1,990,914 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $38.9K | 700,197 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $38.4K | 3,915,000 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $35.6K | 8,663,673 | 0.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $25.6K | 3,180,601 | 0.0% |
| Savara Inc(SVRA) | COM | 805111101 | $22.7K | 11,622,598 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $21.8K | 2,500,000 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $19.8K | 4,702,996 | 0.0% |
| Eqrx Inc | COM | 26886C107 | $19.4K | 10,003,573 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $16.2K | 1,822,883 | 0.0% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $14.8K | 3,130,422 | 0.0% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $14.4K | 1,408,901 | 0.0% |
| Rapid Micro Biosystems Inc(RPID) | CLASS A COM | 75340L104 | $11.0K | 8,434,560 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $10.8K | 2,204,449 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $10.6K | 12,202,510 | 0.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $9.9K | 1,431,058 | 0.0% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $8.9K | 2,805,413 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $7.6K | 1,921,790 | 0.0% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $5.7K | 2,124,694 | 0.0% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $5.5K | 2,000,000 | 0.0% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $2.6K | 640,631 | 0.0% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $1.6K | 5,347,689 | 0.0% |
| Aptinyx Inc | COM | 03836N103 | $1.1K | 8,891,758 | 0.0% |
| Newamsterdam Pharma Company | *W EXP 11/22/202 | N62509117 | $184 | 100,000 | 0.0% |